{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:05:34Z","timestamp":1777446334607,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Secretar\u00eda de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","award":["ECS11-002"],"award-info":[{"award-number":["ECS11-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1155-7","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:13:21Z","timestamp":1563279201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Jock Chichaco","family":"Kuruc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6516-9427","authenticated-orcid":false,"given":"Armando A.","family":"Durant-Archibold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Trachtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gorenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Vannberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1078155214531513","volume":"21","author":"J Greene","year":"2015","unstructured":"Greene J, Hennessy B. The role of anthracyclines in the treatment of early breast cancer. J Oncol Pharm Pract. 2015;21:201\u201312.","journal-title":"J Oncol Pharm Pract"},{"key":"1155_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/bcp.13008","volume":"82","author":"F Aminkeng","year":"2016","unstructured":"Aminkeng F, Ross CJ, Rassekh SR, Hwang S, Rieder MJ, Bhavsar AP, Smith A, Sanatani S, Gelmon KA, Bernstein D, Hayden MR, Amstutz U, Carleton BC. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol. 2016;82:683\u201395.","journal-title":"Br J Clin Pharmacol"},{"key":"1155_CR3","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S1470-2045(15)00079-0","volume":"16","author":"N Turner","year":"2015","unstructured":"Turner N, Biganzoli L, Di Leo A. Continued value of adjuvant anthracyclines as treatment for early breast cancer. Lancet Oncol. 2015;16:e362\u20139.","journal-title":"Lancet Oncol"},{"key":"1155_CR4","first-page":"227","volume":"23","author":"DL Hershman","year":"2009","unstructured":"Hershman DL, Shao T. Anthracycline cardiotoxicity after breast cancer treatment. Oncology (Williston Park). 2009;23:227\u201334.","journal-title":"Oncology (Williston Park)"},{"key":"1155_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185\u2013229.","journal-title":"Pharmacol Rev"},{"key":"1155_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/annonc\/mdf118","volume":"13","author":"LC Kremer","year":"2002","unstructured":"Kremer LC, van Dalen EC, Offringa M, Vo\u00fbte PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002;13:503\u201312.","journal-title":"Ann Oncol"},{"key":"1155_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1517\/14656566.8.8.1039","volume":"8","author":"E Barry","year":"2007","unstructured":"Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother. 2007;8:1039\u201358.","journal-title":"Expert Opin Pharmacother"},{"key":"1155_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11936-017-0520-z","volume":"19","author":"X Wang","year":"2017","unstructured":"Wang X, Zabell A, Koh W, WilsonTang WH. Lamin a\/C cardiomyopathies: current understanding and novel treatment strategies. Cur Treat Options Cardio Med. 2017;19:21.","journal-title":"Cur Treat Options Cardio Med"},{"key":"1155_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/ejhf.1241","volume":"10","author":"RA Al-Saaidi","year":"2018","unstructured":"Al-Saaidi RA, Rasmussen TB, Birkler RID, Palmfeldt J, Beqqali A, Pinto YM, Nissen PH, Baandrup U, M\u00f8lgaard H, Hey TM, Eiskj\u00e6r H, Bross P, Mogensen J. The clinical outcome of LMNA missense mutations appears to be associated with the amount of mutated protein in the nuclear envelope. Eur J Heart Fail. 2018;10:1404\u201312.","journal-title":"Eur J Heart Fail"},{"key":"1155_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","volume":"41","author":"MR Taylor","year":"2003","unstructured":"Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L. Natural history of dilated cardiomyopathy due to Lamin a\/C gene mutations. J Am Coll Cardiol. 2003;41:771\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1155_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cell.2013.02.015","volume":"152","author":"KH Schreiber","year":"2013","unstructured":"Schreiber KH, Kennedy BK. When lamins go bad: nuclear structure and disease. Cell. 2013;152:1365\u201375.","journal-title":"Cell"},{"key":"1155_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/emm.2007.13","volume":"39","author":"K Song","year":"2007","unstructured":"Song K, Dube M, Lim J, Hwang I, Lee I, Kim JJ. Lamin a\/C mutations associated with familial and sporadic cases of dilated cardiomyopathies in Koreans. Exp Mol Med. 2007;39:114\u201320.","journal-title":"Exp Mol Med"},{"key":"1155_CR13","doi-asserted-by":"publisher","first-page":"s136","DOI":"10.1016\/S0735-1097(02)80599-X","volume":"39","author":"R Anan","year":"2002","unstructured":"Anan R, Niimura H, Sasaki T, Seidman JG, Seidman CE, Minagoe S, Tei C. A novel Lamin a\/C missense mutation in a family with autosomal dominant dilated cardiomyopathy with conduction abnormalities. J Am Coll Cardiol. 2002;39:s136.","journal-title":"J Am Coll Cardiol"},{"key":"1155_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","volume":"39","author":"E Arbustini","year":"2002","unstructured":"Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a Lamin a\/C defect-related disease. J Am Coll Cardiol. 2002;39:981\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"1155_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjcard.2004.03.029","volume":"94","author":"M Hermida-Prieto","year":"2004","unstructured":"Hermida-Prieto M, Monserrat L, Castro-Beiras A, Laredo R, Soler R, Peteiro J, Rodriguez E, Bouzas B, Alvarez N, Muniz J, Crespo-Leiro M. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with Lamin a\/C gene mutations. Am J Cardiol. 2004;94:50\u20134.","journal-title":"Am J Cardiol"},{"key":"1155_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/jmg.2004.023283","volume":"42","author":"N Sylvius","year":"2005","unstructured":"Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan KL, Tang AS, Dyack S, Grzybowski J, Ruzyllo W, McBride H, Tesson F. In vivo and in vitro examination of the functional significances of novel Lamin gene mutations in heart failure patients. J Med Genet. 2005;42:639\u201347.","journal-title":"J Med Genet"},{"key":"1155_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000116","volume":"1","author":"M Wasielewski","year":"2014","unstructured":"Wasielewski M. Van Spaendonck-Zwarts KY, Westerink ND , Jongbloed JD, Postma a, Gietema JA, van Tintelen JP , van den berg MP. Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy. Open Heart. 2014;1:e000116.","journal-title":"Open Heart"},{"key":"1155_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cardfail.2017.03.003","volume":"23","author":"M Linschoten","year":"2017","unstructured":"Linschoten M, Teske AJ, Baas AF, Vink A, Dooijes D, Baars HF, Asselbergs FW. Truncating titin (TTN) variants in chemotherapy-induced cardiomyopathy. J Card Fail. 2017;23:476\u20139.","journal-title":"J Card Fail"},{"key":"1155_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/annonc\/mdr272","volume":"22","author":"AC Young","year":"2011","unstructured":"Young AC, Mercer B, Perren TJ, Dodwell D. Anthracycline-induced cardiomyopathy in siblings with early breast cancer. Ann Oncol. 2011;22:1692.","journal-title":"Ann Oncol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1155-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T23:12:21Z","timestamp":1594768341000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1155-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this research were in accordance with the ethical standards of the Panamanian Bioethics Committee, and with the 1964 Helsinki declaration. All participants in this report voluntarily agreed to participate and signed written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}